Change in serum insulin, however, did not reach statistical significance in any group ( Figure 2 ).
← all excerpts
Comparison of Canagliflozin, Dapagliflozin and Empagliflozin Added to Heart Failure Treatment in Decompensated Heart Failure Patients With Type 2 Diabetes Mellitus.
1
—
—